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Abstract
Background: A ubiquitous issue in research is that of selecting a representative sample from the study population.
While random sampling strategies are the gold standard, in practice, random sampling of participants is not always
feasible nor necessarily the optimal choice. In our case, a selection must be made of 12 hospitals (out of 89 Dutch
hospitals in total). With this selection of 12 hospitals, it should be possible to estimate blood use in the remaining
hospitals as well. In this paper, we evaluate both random and purposive strategies for the case of estimating blood
use in Dutch hospitals.
Methods: Available population-wide data on hospital blood use and number of hospital beds are used to simulate
five sampling strategies: (1) select only the largest hospitals, (2) select the largest and the smallest hospitals
(‘maximum variation’), (3) select hospitals randomly, (4) select hospitals from as many different geographic regions
as possible, (5) select hospitals from only two regions. Simulations of each strategy result in different selections of
hospitals, that are each used to estimate blood use in the remaining hospitals. The estimates are compared to the
actual population values; the subsequent prediction errors are used to indicate the quality of the sampling strategy.
Results: The strategy leading to the lowest prediction error in the case study was maximum variation sampling,
followed by random, regional variation and two-region sampling, with sampling the largest hospitals resulting in
the worst performance. Maximum variation sampling led to a hospital level prediction error of 15 %, whereas
random sampling led to a prediction error of 19 % (95 % CI 17 %-26 %). While lowering the sample size reduced
the differences between maximum variation and the random strategies, increasing sample size to n = 18 did not
change the ranking of the strategies and led to only slightly better predictions.
Conclusions: The optimal strategy for estimating blood use was maximum variation sampling. When proxy data
are available, it is possible to evaluate random and purposive sampling strategies using simulations before the start
of the study. The results enable researchers to make a more educated choice of an appropriate sampling strategy.
Keywords: Sampling strategy, Hospital selection, Representativeness, Random vs. purposive sampling, Maximum
variation, Simulation, Model-based inference
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Background
When choosing a sample of participants, researchers
often find themselves with a trade-off between the wish
for randomization and pragmatic considerations. Ran-
dom sampling is the gold standard of sampling strategies
because of its unbiasedness and the possibility to evalu-
ate the reliability (precision) of the resulting estimates
[1–4]. Random sampling is not, however, always feasible
in practice due to constraints in time, resources and
costs, and researchers in the medical field often use a
‘convenience’ or a purposive sample, i.e. by choosing
participants who are easy to recruit or by selecting par-
ticipants based on preferences or expectations.
Fortunately, some studies suggest that such purposive
strategies can lead to representative samples [5–7],
where a sample is considered representative when either
sample characteristics or inferences from the sample ap-
proximate population values. Also, the statement that a
random sample is unbiased means that it will provide a
representative estimate on average. The probability of
randomly drawing an ‘unrepresentative’ sample is large if
your population is small; the estimator is not robust,
since data collection is done only once and not a thou-
sand times. This can be illustrated by a study in the
medical field that compared a randomized study design
with a nonrandomized design. The nonrandomized de-
sign resulted in a more representative sample in 34 % of
cases [5]. In another study, comparison of several sam-
pling strategies for the surveillance of cases of injury and
poisoning in accident and emergency departments
showed that a well-planned systematic sampling strategy
can generate data of equal quality to surveillance includ-
ing all patients [7]. In a study estimating drug use
characteristics, purposive samples were found to be suf-
ficiently representative, as compared to probabilistic
strategies, when these were drawn from a wide cross-
section of participants and included a relatively large
number of individuals [6]. Thus non-probabilistic strat-
egies are sufficient at least in some cases.
If possible, strategies should be evaluated per study, in
line with the ‘fit for use’ concept; see [8,9]). Preferably
this evaluation should be done prior to the actual data
collection so that this information can be used to choose
the optimal sampling strategy. However, in the medical
field, to our knowledge, no (simulation) studies exist that
evaluate random versus preferential sampling strategies
with respect to prediction accuracy before data collec-
tion; instead, methods exist for generalizing treatment
effects in randomized trials from unrepresentative sam-
ples (see for example [5,10–12]), or studies that either
compare only non-probabilistic [13,14] or only probabil-
istic strategies [15].
In the present study, in order to find the optimal strat-
egy, we compare five stratified probabilistic (i.e.,
containing a random element) and purposive (more
broadly: non-probabilistic) sampling strategies that
match real-life strategies used in practice. The goal is to
find the strategy that results in the most representative
sample of hospitals, which in this paper we define as a
sample that allows us to estimate blood use in the
remaining hospitals with a prediction error as low as
possible. The case is based on an actual ongoing study
(named PROTON II; www.proton2.nl), in which we
want to study optimal blood use and benchmark Dutch
hospitals. The resulting database (containing data from
12 selected hospitals) will include detailed information
on patient diagnoses and clinical parameters that can be
used to answer several research questions concerning
blood use, such as: ‘Which patient groups receive blood
(and how much) in terms of patient age, diagnosis and
surgical procedures?‘and “What are determinants and
triggers of blood use?’. Ideally we would include all
Dutch hospitals, but this is not possible since the
process of extracting large amounts of data was found to
be complicated and time-consuming, mainly due to vari-
ation between hospitals and the electronic information
systems that they used. Therefore, a selection must be
made of 12 hospitals (out of 89 in total).
For the simulation, we used a limited amount of data
that was already available for each hospital before data
collection. Five pragmatic sampling strategies were simu-
lated (stratified to hospital type as stratification has been
proven beneficial [16]): 1). Largest hospitals sampling
(resulting in a large database), 2) Maximum variation
sampling (only hospitals on the most extreme ends of
red blood cell use are sampled), 3) Random sampling,
4), Regional variation sampling (hospitals from each re-
gion are included) and 5) Two geographic regions sam-
pling. Representativeness of the resulting samples is
evaluated by performing model based inference and
computing the prediction errors [17]. We assume that
if a sample is representative in this restricted dataset, it
will also be representative for other relevant population
outcomes. The results will show whether or not, in the
context of estimating blood use, the general consensus
that non-probabilistic strategies are inferior to prob-
abilistic strategies holds. More broadly, the case illus-
trates a method for evaluating different sampling
strategies. The results can be used to support an in-
formed choice of sampling strategy.
Methods
Five pragmatic sampling strategies (see below) are simu-
lated using information that is already available prior to
the actual data collection. The effect of sampling strategy
is evaluated in terms of its accuracy in predicting the
population estimates and the margin of error.
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Case and data
The target population consists of all non-specialized
Dutch hospitals (n = 89), comprising 8 academic centres,
28 teaching hospitals and 53 remaining general (smaller)
hospitals. Specialized centres were excluded (n = 3), be-
cause the majority of blood transfusions is already cov-
ered by the academic and peripheral hospitals. Limited
data on all hospitals was already available and easily ac-
cessible. Firstly, the number of beds per hospital was ex-
tracted from annual hospital reports or the hospital
website. Secondly, hospitals were classified by type, as
described by Dutch Hospital Data [18]: a hospital is ei-
ther an academic medical centre, teaching hospital or
general hospital. Proxy information on hospital blood
use was available as well. Sanquin Blood Bank granted
permission for accessing data on the number of issued
blood products delivered to each hospital in the year
2013 for the three main product types: red blood cell
products (RBC), fresh frozen plasma products (FFP) and
platelet products (PLT) [19]. Requests for access to these
data may be addressed to the Vice Chair Executive Board
of Sanquin. The number of issued blood products was
used as a proxy for the number of transfused blood prod-
ucts. If information on blood use was not available for a
hospital, that hospital was excluded from the analysis
(n = 1). Classification of hospitals into organizational
healthcare regions was done according to the Education
and Research regions [20]; hospitals that were not clas-
sified by this structure (n = 8) were manually assigned
based on their location to the nearest region.
Sampling strategies
The simulation is confined to the following five strat-
egies, which are all stratified to hospital type with a fixed
sample size ratio of 1:1:1 of the strata: 1) Maximum
variation sampling (MAXVAR) is used to sample hospi-
tals that have the highest and lowest number of RBC
transfusions, so that variation in the total number of
RBCs is maximized. The theoretical advantage of max-
imum variation sampling is that extrapolating to ex-
treme (impossible) values does not occur because the
extremes are already in the sample. Selecting hospitals
based on their RBC use is also supposedly sufficient for
obtaining high variation in FFP and PLT use; the re-
spective Spearman’s rank correlations with RBC use are
.88 (p < .00001) and .92 (p < .00001). 2) Sampling only
the largest hospitals (LARG) has the obvious advantage
that since larger hospitals have more patients, this yields
the most data. 3) Random sampling (RAND) gives each
hospital within a stratum an equal probability of being
sampled. 4) Regional variation sampling (REGVAR)
maximizes the number of randomly chosen
organizational health care regions (n = 7) included for
each stratum, based on the assumption that there is con-
siderable variation between regions that must be
reflected in the sample. 5) Sampling from two
organizational health care regions (2REG). Including a
large part of all hospitals from two regions allows not
only the benchmarking of hospitals, but also the bench-
marking of (almost) complete regions. This form of sam-
pling is simulated for all 21 combinations of two
regions. If a region contains more hospitals than the pre-
ferred sample size per stratum, hospitals are selected
randomly. In contrast, if a region contained fewer hospi-
tals than the preferred sample size within a stratum, all
hospitals within that stratum are included. Figure 1a il-
lustrates which hospitals are sampled when using the
purposive strategies LARG and MAXVAR. Figure 1b
shows a possible result of sampling when the RAND,
REGVAR and 2REG strategies are used. The RAND,
Fig. 1 Illustration of sampling strategies. a Hospitals that are selected when using the non-probabilistic strategies of sampling the larges hospitals
(LARG) and maximum variation (MAXVAR); b Possible selection of hospitals when the probabilistic RAND, REGVAR and 2REG strategies are
conducted (since these strategies involve a random element, the figure shows only one of many possible samples)
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REGVAR and 2REG strategies can all be classified as
probabilistic or as they contain a random component, and
will collectively be referred to as ‘the random strategies’.
Sample size
Sample size is varied, starting with four hospitals per
stratum (n total = 12). In each subsequent scenario the
added value of including two more of each type of hos-
pital (thus 6 hospitals per stratum) is examined, as well
as the effect of including two hospitals fewer in each
stratum (see Table 1 for all three sample size scenarios).
The stratification by hospital type ensures a fixed sample
size ratio of the strata of 1:1:1. The exception is the
strategy of sampling two regions; here, since there is
usually only one academic hospital per region, the num-
ber of included academic hospitals is fixed in all scenar-
ios at two (and three when the region Noord-Holland is
included).
Model-based inference
Model-based inference, since it may provide a viable al-
ternative for design-based methods when design infor-
mation is not available [21], seems most appropriate for
non-probabilistic sampling. Even if a non-probabilistic
sample in itself is not representative, the resulting model
might very well be [22]. In the present case, model based
inference was used to predict hospital blood use. A Pois-
son distribution was fitted because the outcomes are
count data, and the association between number of beds
and number of products, when stratified to hospital type,
seems exponential. In short, a data sample drawn accord-
ing to one of the above strategies was used to fit a Poisson
regression model that predicts blood use (i.e., the number
of RBC, FFP and PLT per hospital) as a function of hos-
pital size (i.e., number of beds) and hospital type. With the
obtained prediction models, RBC, FFP and PLT use is esti-
mated for all Dutch hospitals and compared to the true
population values, which are known for this case. For each
of the three blood products, outcomes are: 1) the hospital
level prediction error and 2) the national level prediction
error. For the hospital level error, the absolute prediction
error of the number of products is calculated for each hos-
pital. These errors are summed over all hospitals and the
resulting ‘absolute error’ is expressed as a percentage of
the total number of products, i.e. the population value.
For the national level prediction error, the predictions for
all hospitals are summed, resulting in an estimate of the
total number of products. The difference between this ‘na-
tional estimate’ and the actual population value is the ‘na-
tional error’, which is also expressed as a percentage of the
population value. These two error types are of interest for
different reasons. National level errors are important from
the perspective of the national blood bank: since the blood
bank produces blood products for the whole of the
Netherlands, it is relevant to know how much blood is
needed in total, for example on a yearly basis. However
from the perspective of (clinical) studies, it might be con-
sidered more important to have accurate predictions also
within each hospital (i.e., at the hospital level). Obviously,
individual hospitals are also interested in their own ex-
pected blood use.
Simulations
For each of the RAND, REGVAR and 2REG strategies, a
random sampling process is simulated a thousand times.
The median error percentages are reported, with the
95 % centiles and the average error percentages. Since
the strategy of sampling two regions encompasses 21
unique combinations of two regions, the median and
average error percentages are taken over all sampled
combinations. Striking differences between combinations
of regions are described in the results section. All ana-
lyses are performed in R Version 3.0.0.
Results
Prediction error at the hospital level
Prediction errors for each sampling strategy are shown
in Table 2, for the scenario of sampling 12 hospitals. For
RBC, FFP and PLT, maximum variation sampling out-
performed largest hospitals sampling in terms of hospital
level error (Fig. 2). Similarly, MAXVAR consistently out-
performed the random strategies (RAND, REGVAR and
2REG). MAXVAR sampling resulted in a 15 % predic-
tion error at the hospital level for RBC, whereas the ran-
dom strategies (stratified random, regional variation and
two regions) had a slightly higher median error for RBC
(namely 19 %, 19 %, and 20 % respectively), for FFP
(30 %, 29 % and 34 % versus 25 % for MAXVAR), and
for PLT (32,31 % and 35 % versus 28 % for MAXVAR).
Of all the simulations, RAND resulted in a lower hos-
pital level error than MAXVAR in none (RBC), 3 %
(FFP) and 14 % (PLT) of the simulations (Table 3). Sam-
pling only the largest hospitals resulted in a hospital
level error of 40 % for RBC, which is higher than the
median errors for the random strategies.
Prediction error at the national level
Comparing the national level prediction errors of the
strategies resulted in a similar pattern, with MAXVAR
Table 1 Number of hospitals included per type for each sample
size scenario
Scenario N (academic) N (teaching) N (general) N Total (% of all
Dutch hospitals)
A 4 4 4 12 (13 %)
B 6 6 6 18 (20 %)
C 2 2 2 6 (7 %)
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Table 2 Comparison of prediction errors for the five sampling strategies, for n = 12 (n = 4 per hospital type)
Strategy Prediction error at hospital level Prediction error at national level
RBC FFP PLT RBC FFP PLT
LARG 40 % 28 % 35 % 40 % 17 % 20 %
MAXVAR 15 % 25 % 28 % 2 % 1 % 17 %
RAND (median; mean,
95 % centiles)
19 %; 20 % (17 %-26 %) 30 %; 31 % (25 %-42 %) 32 %; 32 % (25 %-40 %) 5 %; 6 % (0 %-18 %) 10 %; 11 % (1 %-30 %) 9 %; 10 % (0 %-28 %)
REGVAR (median; mean,
95 % centiles)
19 %; 20 % (16 %-26 %) 29 %; 30 % (25 %-41 %) 31 %; 31 % (24 %-39 %) 6 %; 7 % (0 %-18 %) 9 %; 11 % (1 %-30 %) 9 %; 10 % (0 %-27 %)
2REG (median; mean,
95 % centiles)
20 %; 21 % (17 %-29 %) 34 %; 49 % (27 %-135 %) 35 %; 44 % (30 %-43 %) 5 %; 6 % (0 %-17 %) 11 %; 26 % (1 %-118 %) 8 %; 16 % (0 %-76 %)
LARG = largest hospitals, MAXVAR =maximum variation in number of RBCs, RAND = random, REGVAR = regional variation, 2REG = two regions, RBC = red blood cell products, FFP = fresh frozen plasma products,
PLT = platelet products. Output for RAND, REGVAR and 2REG is based on the average of 10 times 1000 simulations and accompanied by 95 % centiles. Outcomes are the prediction error at hospital level (summed
absolute errors at hospital level) and the national prediction error (absolute deviation of the national estimate from the population values), both expressed as a percentage from the population values
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marginally but consistently outperforming the random
strategies most of the time (Table 2 and Fig. 2). In fact,
random sampling resulted in a lower national level error
than MAXVAR in 25 % (RBC), 3 % (FFP) and 79 %
(PLT) of the simulations (Table 3), with PLT being the
exception. The same pattern was found for REGVAR
and 2REG.
Effect of sample size
Increasing the sample size did not affect the overall
ranking of the sampling strategies by prediction error;
the scenarios n = 12, n = 18 and n = 6 all resulted in a
preference for MAXVAR. Adding two more academic,
two more teaching and two more general hospitals to
the sample (total n = 18) reduced hospital and national
Table 3 How often are predictions of blood use better for random than for purposive sampling strategies?
RAND versus: MAXVAR LARG
RBC FFP PLT RBC FFP PLT
Lower hospital level prediction error for RAND 0 % 3 % 14 % 100 % 35 % 84 %
Lower national level prediction error for RAND 25 % 3 % 79 % 100 % 81 % 87 %
REGVAR versus: MAXVAR LARG
Lower hospital level prediction error for REGVAR 0 % 6 % 25 % 100 % 44 % 90 %
Lower national level prediction error for REGVAR 20 % 4 % 79 % 100 % 79 % 88 %
2REG versus: MAXVAR LARG
Lower hospital level prediction error for 2REG 0 % 0 % 0 % 100 % 9 % 52 %
Lower national level prediction error for 2REG 24 % 3 % 83 % 100 % 70 % 88 %
Percentage of all simulations that the random strategies (RAND, REGVAR and 2REG) outperform the purposive strategies (MAXVAR and LARG) in terms of hospital
and national level prediction error for n = 12 (n = 4 per hospital type)
RBC FFP PLT
100
50
0
50
100
LARG MAXVAR RAND REGVAR 2REG LARG MAXVAR RAND REGVAR 2REG LARG MAXVAR RAND REGVAR 2REG
Sampling strategy
P
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di
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Fig. 2 Prediction error at hospital and national level for n(academic) = 4, n(teaching) = 4 and n(general) = 4. Median prediction errors of red blood
cell (RBC), plasma (FFP) and platelet (PLT) use, for different sampling strategies. 95 % centiles are provided for the strategies involving a random
element. Number of simulations = 1000. LARG = largest hospitals, MAXVAR =maximum variation in number of RBCs, RAND = random, REGVAR =
regional variation, 2REG = two regions
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level error as well as the 95 % percentile error ranges by
approximately two absolute percent points, but not al-
ways (see Additional file 1). Decreasing the sample size
to two hospitals per hospital type (total n = 6) reduced
the difference between MAXVAR and the random strat-
egies. Also, decreasing sample size increased prediction
errors considerably in some cases, especially for the
LARG strategy. For LARG, both hospital and national
level error for RBC increased from 40 % to 92 %. For
MAXVAR, hospital level errors increased from 15 % to
23 % (RBC), 25 % to 37 % (FFP) and 28 % to 40 % (PLT);
national level errors increased by three percent points.
Similarly, the random strategies yielded moderately
higher hospital and national errors and wider 95 %
centile ranges in the low sample size scenario (see
Additional file 2).
Discussion
Currently, the representativeness of a sample is often
only checked after data collection has finished. Although
such a post-hoc evaluation may provide some insight
into the representativeness of the already selected sam-
ple, unfavourable outcomes can rarely be mitigated once
the data collection process has ended. Therefore an
evaluation of potential sampling strategies should ideally
be performed prior to data collection. We evaluated five
pragmatic sampling strategies for the case of estimating
blood use in Dutch hospitals. The evaluation consists of
simulating the sampling processes for five probabilistic
and non-probabilistic strategies, using prior knowledge.
Such a simulation study may help in deciding whether a
random sampling design is necessary or whether vari-
ation should be aimed for in order to obtain a sample
that is likely to be representative of population values.
This type of evaluation is in theory applicable to a broad
array of research fields, provided that there exists an as-
sociation between a predictor and outcome that can be
modelled and data are available before the actual study.
The case study illustrates that random sampling,
which is considered the gold standard, is not necessarily
the optimal sampling strategy. In fact, of the five strat-
egies considered, the optimal strategy in our case was
maximum variation sampling (MAXVAR). A sample se-
lected using the MAXVAR strategy led to better predic-
tions of red blood cell unit (RBC) use than a random
sample in all (at the hospital level) or most (at the na-
tional level) of the simulations. In contrast, random sam-
pling did perform much better than sampling only the
largest hospitals. In general, the same pattern was found
for both national and hospital level prediction errors,
with national errors being lower since under- and over-
estimation of individual hospitals cancel each other out.
Differences between MAXVAR and the random strat-
egies appear small but consistent.
The preference for the non-probabilistic MAXVAR
strategy over random sampling was not completely ex-
pected in the context of previous literature. In a previous
study that simulated outcomes of a randomized design
[5], non-probabilistic sampling was reported to be better
in only 34 % of simulations. Moreover, in a study on
modelling species distribution, non-probabilistic strat-
egies were reportedly inferior to probabilistic strategies
[23]. These contrasting findings could be due to the use
of different measures for evaluating representativeness:
in the present study a sample is considered representa-
tive if it gives us an unbiased estimate of the outcome
studied, whereas in other studies, representativeness is
defined in terms of whether participants in the sample
have similar characteristics as those in a random sample.
Moreover, these contrasting findings could be caused by
the use of different data and models for inference, and
the use of a convenience sample instead of systematic
purposive samples as in the present study. However, in
line with earlier findings [5], differences between the
median prediction errors for MAXVAR and the random
strategies were quite small. This implies a trade-off be-
tween the certainty of a known prediction error with
MAXVAR and the risk of potentially getting a higher (or
a lower) error with one of the random strategies.
In the present study, MAXVAR seems the ‘safest’ op-
tion. However, MAXVAR was not consistently the pre-
ferred strategy. In accordance with findings from an
ecological study [16], preference for either a non-
probabilistic or a probabilistic strategy turned out to de-
pend on which outcome was modelled. For example,
MAXVAR outperformed random sampling for the out-
come platelet (PLT) use at the hospital level, but not at
the national level. Apparently for national level predic-
tions of PLT use, MAXVAR results in a systematic devi-
ation (i.e., predictions per hospital do not cancel each
other out). This result might be explained by differences
in the underlying distributions of the outcomes pre-
dicted. Compared to RBC use, the distribution of PLT
use has more extreme values, as PLT use is relatively
high in the largest hospitals and varies greatly between
hospitals (partly due to its high spilling rate and short
shelf life). In case the outcome distribution does not
have values that are too extreme or when the association
between predictor and outcome is more or less linear,
MAXVAR seems to perform well. However for other
distributions, an amended MAXVAR strategy might be
more suitable. Such a strategy could for instance
maximize the distances between subsequent hospitals
(instead of sampling at the ends of the distribution).
Choosing an appropriate variable for which maximum
variation is obtained is important, since this can have
substantial consequences for the estimates [16]. Ultim-
ately, whether prediction accuracy at the hospital or at
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the national level is given more importance depends on
the aim and perspective of the researcher. From the per-
spective of the blood bank that produces blood products
for the whole of the Netherlands, it is important to know
how much blood is needed nationally on a yearly basis.
However from the perspective of (clinical) studies and
individual hospitals, it would be more important to have
accurate predictions also within each hospital.
Increasing the sample size from 12 to 18 hospitals did
not alter the order of the strategies. In contrast, decreas-
ing the sample size to 6 hospitals diminished the advan-
tage of MAXVAR sampling over the random strategies.
Apparently a very low sample size in MAXVAR sam-
pling allows outlier hospitals to impact the model esti-
mates more heavily, leading to relatively high prediction
errors. In comparison, in a study on habitat suitability
modelling [24], increasing or decreasing sample size did
not change the order of strategies, however that study
did not consider scenarios with a sample size as small as
n = 6. In that study, prediction accuracy increased with
sample size, whereas in our study the gain in prediction
accuracy for n = 18 as compared to n = 12 was quite
small (around 1–2 absolute percentage points). Pres-
ently, for estimating blood use it is not directly obvious
that including six additional hospitals would be worth
the additional effort. Instead, a more accurate prediction
of blood use might have been obtained by extending the
model with more detailed information (predictors), such
as the presence of a cardiac centre in a hospital and
number of patients per admission diagnosis or type of
surgery.
An important assumption that underlies our evalu-
ation is that representativeness in terms of a known out-
come can be used as a proxy for representativeness for
other outcomes (which will be studied after the actual
data collection). The reasoning behind this assumption
is that if a sample is at least representative for the
number of blood products, it is more likely to be repre-
sentative for related outcomes as well. These related out-
comes, such as the distribution of blood products over
diagnoses and surgeries, blood use in different patient
subgroups, and transfusion triggers, are all expected to
be related to the predictors hospital type and hospital
size. A second assumption made is that a limited nation-
wide data set is available. If no such proxy data would be
available, an option would be to simulate the data set as
well. Further research could investigate what the optimal
sampling strategy would be for different assumptions
about the distributions and associations within the data.
Finally, we acknowledge that other considerations such
as costs, feasibility, the need to include specific regions
for benchmarking purposes, specific patient groups, or
certain hospitals from which historical data are already
available (which enables a trend analysis), might play a
role in selecting potential participants. These conditions
can also be included in the simulation. Last but certainly
not trivial, the success of the data selection depends on
the cooperation of the potential participants.
Conclusion
A simulation study as described above may offer guid-
ance in choosing an appropriate sampling strategy and
size before data collection is started. Following this guid-
ance is straightforward and can be done with limited re-
sources. Its only requirement is the a priori availability
of a (limited) nationwide data set, which will often be
available as long as the aggregation level is sufficiently
high. In many situations, especially whenever data col-
lection has large resource requirements, such a simula-
tion will be worthwhile and should therefore be
considered.
Availability of data and materials
Availability of the data used is not necessary as not the
data itself but the simulation method is of interest.
Instead we provide the R code that creates an exemplary
data set and simulates the sampling strategies
(Additional file 3).
Additional files
Additional file 1: Comparison of prediction errors for the five
sampling strategies, for n = 18 (n = 6 per hospital type). File legend:
LARG = largest hospitals, MAXVAR =maximum variation in number of
RBCs, RAND = random, REGVAR = regional variation, 2REG = two regions,
RBC = red blood cell products, FFP = fresh frozen plasma products, PLT =
platelet products. Output for RAND, REGVAR and 2REG is accompanied
by 95 % centiles. Description: These show the prediction errors for n = 18
in a similar table as for n = 12. (XLSX 10 kb)
Additional file 2; Comparison of prediction errors for the five
sampling strategies, for n = 6 (n = 2 per hospital type). File legend:
LARG = largest hospitals, MAXVAR =maximum variation in number of
RBCs, RAND = random, REGVAR = regional variation, 2REG = two regions,
RBC = red blood cell products, FFP = fresh frozen plasma products, PLT =
platelet products. Output for RAND, REGVAR and 2REG is accompanied
by 95 % centiles. Description: These show the prediction errors for n = 6
in a similar table as for n = 12. (XLSX 9 kb)
Additional file 3: R code for simulating sampling strategies.
Description: R code that creates an exemplary data set and simulates
the sampling strategies. (R 26 kb)
Abbreviations
RBC: Red blood cell unit; FFP: Fresh frozen plasma unit; PLT: Platelet unit;
LARG: Strategy of sampling only the largest hospitals; MAXVAR: Strategy of
sampling with maximum variation in number of RBCs; RAND: Strategy of
random sampling; REGVAR: Strategy of sampling with regional variation;
2REG: Strategy of sampling from two regions.
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